Tecrea
Tecrea Ltd is a pioneering company in the field of molecular science, utilizing nanotechnology to develop innovative cell and tissue delivery tools. Their mission is to empower the biomedical community with effective transfection, drug delivery, and reformulation technologies that are fully translatable from lab to clinic, supporting advancements in healthcare and life sciences.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Plasmid DNA transfection reagent (nanoparticle-based)
Reagent engineered for highly efficacious DNA transfection into mammalian cells with standard lab workflows.
RNA transfection reagent (nanoparticle-based)
RNA delivery reagent described as non-toxic and compatible with clinical development workflows.
Small-molecule delivery reagent (nanoparticle-based)
Formulation designed to deliver small and highly hydrophobic molecules into cells.
Protein and peptide delivery reagent (nanoparticle-based)
Delivery reagent optimised for proteins and peptides to enable cellular uptake and tissue delivery.
Nanocin
Nanocin PRO is specifically engineered for the effective delivery of proteins and peptides, including antibodies, into cells and tissues. It offers a precise, fast-acting, and cost-effective approach to intracellular delivery.
Nanocin PLASMID
Perfectly engineered to enter mammalian cells, Nanocin PLASMID allows for highly efficacious DNA transfection in a range of cell types using cutting-edge nanotechnology.
Plasmid DNA transfection reagent (nanoparticle-based)
Reagent engineered for highly efficacious DNA transfection into mammalian cells with standard lab workflows.
RNA transfection reagent (nanoparticle-based)
RNA delivery reagent described as non-toxic and compatible with clinical development workflows.
Small-molecule delivery reagent (nanoparticle-based)
Formulation designed to deliver small and highly hydrophobic molecules into cells.
Protein and peptide delivery reagent (nanoparticle-based)
Delivery reagent optimised for proteins and peptides to enable cellular uptake and tissue delivery.
Nanocin
Nanocin PRO is specifically engineered for the effective delivery of proteins and peptides, including antibodies, into cells and tissues. It offers a precise, fast-acting, and cost-effective approach to intracellular delivery.
Nanocin PLASMID
Perfectly engineered to enter mammalian cells, Nanocin PLASMID allows for highly efficacious DNA transfection in a range of cell types using cutting-edge nanotechnology.
Services
Direct consultation and protocol support from scientific staff for reagent use, optimisation and application-specific questions.
Collaborative development and licensing of the nanoparticle delivery platform for pharmaceutical and animal health product reformulation and development.
Management and participation in funded industry-academia projects, workshops and masterclasses to develop and scale solutions.
Direct consultation and protocol support from scientific staff for reagent use, optimisation and application-specific questions.
Collaborative development and licensing of the nanoparticle delivery platform for pharmaceutical and animal health product reformulation and development.
Management and participation in funded industry-academia projects, workshops and masterclasses to develop and scale solutions.
Expertise Areas
- Nanoparticle-mediated cellular delivery
- Transfection and nucleic acid delivery
- Protein and peptide delivery
- Small-molecule delivery and formulation
Key Technologies
- Nanoparticle-forming self-assembly
- Non-viral transfection/delivery reagents
- Polyhexanide-based polymer formulations
- Co-delivery/co-transfection methods
News & Updates
A Phase 2b clinical study involving Nanocin technology for a topical antifungal product met its primary endpoint, showing superiority over placebo.
Tecrea has developed Sanzone, a seed coating product using Nanocin platform technology, which has shown promising results in crop growth and yield in Zimbabwe and South Africa.
Tecrea received funding to develop a novel therapy for dairy cows that combines tissue release and infection control, aiming to improve reproductive capabilities and reduce production losses.
A Phase 2b clinical study involving Nanocin technology for a topical antifungal product met its primary endpoint, showing superiority over placebo.
Tecrea has developed Sanzone, a seed coating product using Nanocin platform technology, which has shown promising results in crop growth and yield in Zimbabwe and South Africa.
Tecrea received funding to develop a novel therapy for dairy cows that combines tissue release and infection control, aiming to improve reproductive capabilities and reduce production losses.